Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Adcentrx Therapeutics Receives FDA Fast Track Designation for Nectin-4 ADC in Advanced Cervical Cancer
Wednesday, May 07, 2025Adcentrx Therapeutics has been granted Fast Track designation by the US Food and Drug Administration FDA for its investigational therapy ADRX ADRX is a proprietary ADC created by Adcentrx using its iConjugation technology platform
Genezen and Optieum Biotechnologies Partnership to Advance CAR-T Therapy for Glioblastoma
Tuesday, May 06, 2025Genezen has entered into a partnership with Optieum Biotechnologies The collaboration aims to support the current Good Manufacturing Practice cGMP manufacturing of a lentiviral vector LVV construct for OPTF an innovative CART therapy being developed...
Alterity Therapeutics Granted FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
Monday, May 05, 2025Alterity Therapeutics has been granted Fast Track designation by the US Food and Drug Administration FDA for its lead candidate ATH
Illumina and Ovation.io Introduce Novel Clinical Dataset to Tackle GLP-1 Treatment Challenges
Friday, May 02, 2025Illumina and Ovationio have announced the creation of a major new clinical multiomic dataset focused on glucagonlike peptide GLP receptor agonist therapies
Dimerix Enters into Agreement with Amicus Therapeutics for DMX-200 to Treat FSGS
Thursday, May 01, 2025Dimerix Limited and Amicus Therapeutics have entered an exclusive licensing agreement for the US commercialisation of DMX a Phase investigational treatment for Focal Segmental Glomerulosclerosis FSGS and other indications
Johnson & Johnson Receives FDA Approval for IMAAVY™ to Treat Generalised Myasthenia Gravis
Thursday, May 01, 2025Johnson Johnson has announced that the US Food and Drug Administration FDA has approved IMAAVY nipocalimabaahu a monoclonal antibody that blocks the neonatal Fc receptor FcRn for the treatment of generalised myasthenia gravis gMG
Addex Enters into Agreement with Sinntaxis to Develop mGlu5 Inhibitors in Brain Injury Recovery
Wednesday, April 30, 2025Addex Therapeutics has signed an option and collaboration agreement with Sinntaxis AB Recovery after a stroke or brain injury depends on the brains ability to form new connections or reactivate existing ones
QIAGEN Expands Digital PCR Tools for Lentivirus Quality Control
Wednesday, April 30, 2025QIAGEN has expanded its digital PCR dPCR portfolio with new solutions for lentivirusbased applications which are widely used in the manufacture of advanced treatments such as CART cell therapy a form of personalised cancer immunotherapy
Creyon Bio and Eli Lilly Collaborate on RNA-Targeted Oligo Therapy Development
Wednesday, April 30, 2025Creyon Bio has announced a global research and licensing agreement with Eli Lilly and Company to develop RNAtargeted oligonucleotide oligo therapies
PredxBio Enters into Partnership with Hamamatsu Photonics to Advance Cancer Research and Therapeutic Development
Tuesday, April 29, 2025PredxBio has partnered with Hamamatsu Photonics to bring cuttingedge spatial biology solutions to cancer research and immunooncologyThis collaboration combines Hamamatsus MoxiePlex multiplex immunofluorescence imaging system with PredxBios SpaceIQ
